DRRX DURECT CORP Investments/Divestments 8-K Filing 2023 - Clinical Trial Enrollment DURECT Corp completed enrollment in Phase 2b AHFIRM clinical trial for treatment of severe alcohol-associated hepatitis.Get access to all SEC 8-K filings of the DURECT CORP